Dickkopf 2 Homolog (DKK2) (Middle Region) Peptide
Quick Overview for Dickkopf 2 Homolog (DKK2) (Middle Region) Peptide (ABIN8098865)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- Dkk2 Peptide - middle region
-
Sequence
- NGICIPVTES ILTPHIPALD GTRHRDRNHG HYSNHDLGWQ NLGRPHSKMP
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-Dkk2 Antibody (ARP55047_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- DKK2 (Dickkopf 2 Homolog (DKK2))
-
Background
- Dkk2 antagonizes canonical Wnt signaling by inhibiting LRP5/6 interaction with Wnt and by forming a ternary complex with the transmembrane protein KREMEN that promotes internalization of LRP5/6. DKKs play an important role in vertebrate development, where they locally inhibit Wnt regulated processes such as antero-posterior axial patterning, limb development, somitogenesis and eye formation. In the adult, Dkks are implicated in bone formation and bone disease, cancer and Alzheimer's disease.
-
Molecular Weight
- 28kDa
-
Gene ID
- 56811
-
NCBI Accession
- NP_064661
-
UniProt
- Q9QYZ8
Target
-